Medical treatment on discharge
| Type 1 AMI n=17 488 | Type 2 AMI n=1403 | p Value | OR (95% CI) Type 2 vs. type 1 AMI (multiple adjusted)* | p Value* | |
|---|---|---|---|---|---|
| ACE inhibitors, % | 60.6 | 48.8 | <0.001 | 0.89 (0.76 to 1.03) | 0.102 |
| ARB, % | 16.2 | 18.0 | 0.083 | 1.00 (0.84 to 1.18) | 0.990 |
| β-blockers, % | 87.5 | 81.7 | <0.001 | 0.73 (0.59 to 0.89) | 0.002 |
| Aspirin, % | 92.6 | 74.2 | <0.001 | 0.37 (0.31 to 0.45) | <0.001 |
| Other antiplatelets, % | 81.4 | 46.7 | <0.001 | 0.36 (0.30 to 0.42) | <0.001 |
| Double antiplatelet treatment, % | 75.9 | 40.2 | <0.001 | 0.38 (0.33 to 0.45) | <0.001 |
| Oral anticoagulants, % | 7.4 | 15.6 | <0.001 | 1.30 (1.06 to 1.60) | 0.011 |
| Digoxin, % | 2.3 | 5.8 | <0.001 | 1.14 (0.81 to 1.62) | 0.453 |
| Statins, % | 86.0 | 66.0 | <0.001 | 0.56 (0.47 to 0.68) | <0.001 |
| Diuretics, % | 32.4 | 50.3 | <0.001 | 1.26 (1.08 to 1.47) | 0.003 |
*Adjusted for age, sex, comorbidities and revascularisation during hospitalisation.
AMI, acute myocardial infarction; ARB, angiotensin receptor blocker; ACE, angiotensin converting enzyme.